Schneider MM - Search Results

1

Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis.

Baldassarre T, Watt K, Truesdell P, Meens J, Schneider MM, Sengupta SK, Craig AW. Baldassarre T, et al. Among authors: schneider mm. Mol Cancer Res. 2015 Jun;13(6):1044-55. doi: 10.1158/1541-7786.MCR-14-0573. Epub 2015 Mar 17. Mol Cancer Res. 2015. PMID: 25784716

2

Stromal adipocyte PPARγ protects against breast tumorigenesis.

Skelhorne-Gross G, Reid AL, Apostoli AJ, Di Lena MA, Rubino RE, Peterson NT, Schneider M, SenGupta SK, Gonzalez FJ, Nicol CJ. Skelhorne-Gross G, et al. Carcinogenesis. 2012 Jul;33(7):1412-20. doi: 10.1093/carcin/bgs173. Epub 2012 May 11. Carcinogenesis. 2012. PMID: 22581835

3

Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.

Apostoli AJ, Skelhorne-Gross GE, Rubino RE, Peterson NT, Di Lena MA, Schneider MM, SenGupta SK, Nicol CJ. Apostoli AJ, et al. Among authors: schneider mm. Int J Cancer. 2014 Mar 1;134(5):1055-66. doi: 10.1002/ijc.28432. Epub 2013 Sep 19. Int J Cancer. 2014. PMID: 23934545 Free PMC article.

4

Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression.

Apostoli AJ, Roche JM, Schneider MM, SenGupta SK, Di Lena MA, Rubino RE, Peterson NT, Nicol CJ. Apostoli AJ, et al. Among authors: schneider mm. Mol Cancer. 2015 Apr 15;14:85. doi: 10.1186/s12943-015-0347-8. Mol Cancer. 2015. PMID: 25889730 Free PMC article.

5

Perineural Inflammation as a Novel Feature in Lichen Sclerosus: A Case Series of Histologic and Clinical Features.

Del Papa J, Pucchio AC, Schneider M, Wang A. Del Papa J, et al. Am J Dermatopathol. 2024 May 1;46(5):287-291. doi: 10.1097/DAD.0000000000002640. Epub 2024 Mar 8. Am J Dermatopathol. 2024. PMID: 38457688

6

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M. Schneider M, et al. J Biol Chem. 2002 Jan 11;277(2):1021-30. doi: 10.1074/jbc.M104444200. Epub 2001 Oct 29. J Biol Chem. 2002. PMID: 11684677 Free article.

7

Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis.

Schneider M, Nesheim M. Schneider M, et al. J Thromb Haemost. 2003 Jan;1(1):147-54. doi: 10.1046/j.1538-7836.2003.00028.x. J Thromb Haemost. 2003. PMID: 12871552 Free article.

8

A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma.

Neill EK, Stewart RJ, Schneider MM, Nesheim ME. Neill EK, et al. Among authors: schneider mm. Anal Biochem. 2004 Jul 15;330(2):332-41. doi: 10.1016/j.ab.2004.04.007. Anal Biochem. 2004. PMID: 15203340

9

Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.

Schneider M, Brufatto N, Neill E, Nesheim M. Schneider M, et al. J Biol Chem. 2004 Apr 2;279(14):13340-5. doi: 10.1074/jbc.M313211200. Epub 2004 Jan 8. J Biol Chem. 2004. PMID: 14715654 Free article.

10

A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.

Schneider M, Nesheim M. Schneider M, et al. J Biol Chem. 2004 Apr 2;279(14):13333-9. doi: 10.1074/jbc.M313164200. Epub 2004 Jan 8. J Biol Chem. 2004. PMID: 14715655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page